Welcome!

News Feed Item

Eventide Gilead Fund and Eventide Healthcare & Life Sciences Fund Complete Calendar Year 2013 as WSJ Category Kings

BOSTON, MA -- (Marketwired) -- 01/21/14 -- The Eventide Gilead Fund's no-load share class (NASDAQ: ETGLX) and the Eventide Healthcare & Life Sciences Fund's no-load share class (NASDAQ: ETNHX) were both named as "Category Kings" by the Wall Street Journal for the one-year period ending December 31, 2013, in recognition of ranking within the top 10 funds in their categories (Midcap Growth and Health & Biotech, respectively) for total returns. The Eventide Gilead Fund finished the year ranked #3 out of 412 funds, and the Eventide Healthcare & Life Sciences Fund ranked #6 out of 87 funds.

The Eventide Funds are managed by Eventide Asset Management, LLC, a Boston-based investment advisor that practices values-based investing. For Eventide, values-based investing is a form of investing that seeks to partner with companies that create real value and blessing for their customers, employees, and other stakeholders. "We are pleased with the outperformance of both funds during the past year, as well as since the inception of these funds. We interpret the results as evidence that the principle of service above profits can potentially create reciprocal blessings for businesses and their shareholders," said Eventide's CEO, Robin John. "We strongly believe that value creation is the key indicator of business vitality and a reliable leading indicator of financial performance."

The Eventide Gilead Fund achieved a one-year total return of 52.93%, compared with the Russell Mid-Cap Growth Index return of 35.74% and S&P 500 Index return of 32.39%, outperforming each by 17.19% and 20.54%, respectively. The Eventide Healthcare & Life Sciences Fund achieved a one-year total return of 62.01%, compared with the Healthcare Blended Index return of 51.11% and S&P 500 Index return of 32.39%, outperforming each by 10.9% and 29.62%, respectively.

The following table outlines the Eventide Gilead Fund's performance since inception:

                                                                  Since
                                                                inception
                                    3 year         5 year      (7/08/2008)
                                  annualized     annualized     annualized
As of 12/31/2013 1 year return      return         return         return
---------------- -------------  -------------  -------------  -------------
Eventide Gilead
 Fund*                   52.93%         21.90%         25.67%         17.75%
---------------- -------------  -------------  -------------  -------------
S&P 500 Total
 Return Index            32.39%         16.18%         17.94%          9.43%
---------------- -------------  -------------  -------------  -------------
Russell Mid-Cap
 Growth Total
 Return Index            35.74%         15.63%         23.37%         10.89%
---------------- -------------  -------------  -------------  -------------

The following table outlines the Eventide Healthcare & Life Science Fund's performance since inception:

                                                            Since inception
                                                              (12/27/2012)
                                                               annualized
As of 12/31/2013          3 months return   1 year return        return
------------------------- ---------------  ---------------  ---------------
Eventide Healthcare &
 Life Sciences Fund*                 3.37%           62.01%           61.65%
------------------------- ---------------  ---------------  ---------------
S&P 500 Total Return
 Index                              10.51%           32.39%           32.74%
------------------------- ---------------  ---------------  ---------------
Healthcare Blended Index            10.89%           51.11%           51.23%
------------------------- ---------------  ---------------  ---------------

Three-year and inception returns are annualized. The performance data quoted here represents past performance. Current performance may be lower or higher than the performance data quoted above. Past performance is no guarantee of future results. The investment return and principal value of an investment will fluctuate so that investor's shares, when redeemed, may be worth more or less than their original cost. Please review the funds' prospectus for more information regarding the funds' fees and expenses. Performance shown is for No-load Class shares (please see a prospectus for information about other share classes). For performance information current to the most recent month-end, please call toll-free 877-771-EVEN (3836).

Eventide Gilead Fund Expenses ratios: Gross Expenses 1.75%; Net Expenses 1.64%. The advisor has agreed to maintain the Fund's total annual operating expenses (excluding certain fees and expenses) at 1.42% at least until October 31, 2014.

Eventide Healthcare & Life Sciences Fund Expenses ratios: Gross Expenses 9.51%; Net Expenses 1.64%. The advisor has agreed to maintain the Fund's total annual operating expenses (excluding certain fees and expenses) at 1.43% at least until October 31, 2014.

As of 12/31/2013, the Eventide Gilead Fund had $323,576,279.67 in net assets and the Eventide Healthcare & Life Sciences Fund had $39,745,499.32 in net assets.

Wall Street Journal rankings are not intended to constitute investment advice. As a result, you should not make an investment decision on the basis of this information. Rather, you should use the rankings for informational purposes only.

The S&P 500 is an index created by Standard & Poor's Corp considered to represent the performance of the stock market generally. The Russell Midcap Growth Index measures the performance of the U.S. equity mid-cap growth segment. It includes mid-cap companies with higher price-to-book ratios and forecasted growth. The Healthcare Blended Index is composed of equal parts of the S&P 400 Healthcare Index and the S&P 600 Healthcare Index. These indexes are not investment products available for purchase.

Mutual Funds involve risk including the possible loss of principal. The Eventide Funds can invest in smaller-sized companies which may experience higher failure rates than larger companies and they normally have a lower trading volume than larger companies. The Funds' ethical values screening criteria could cause it to underperform similar funds that do not have such screening criteria. The funds can have risk associated with the biotechnology and pharmaceutical industry in which these companies may be heavily dependent on clinical trials with uncertain outcomes and decisions made by the U.S. Food and Drug Administration. The funds can have risk related to option investing. There are special risks associated with investments in foreign companies including exposure to currency fluctuations, less efficient trading markets, political instability and differing auditing and legal standards. The funds can have risk associated with a higher portfolio turnover, which could result in higher transactional costs. The recent growth rate in the stock market has helped to produce short-term returns that are not typical and may not continue in the future. Because of ongoing market volatility, fund performance may be subject to substantial short-term changes. An investor should consider the Funds' investment objectives, risks, charges and expenses carefully before investing or sending money. This and other important information about Eventide Funds can be found in the Funds' prospectus. Please read the prospectus carefully before investing. To obtain a current prospectus please call the fund, toll free at 877-771-EVEN (3836).

Eventide Funds is distributed by Northern Lights Distributors, LLC, member FINRA, which is not affiliated with Eventide Asset Management, LLC.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Fund Contact:
Jason Myhre
877-771-EVEN (3836)

0195-NLD-1/14/2014

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
Cloud computing is being adopted in one form or another by 94% of enterprises today. Tens of billions of new devices are being connected to The Internet of Things. And Big Data is driving this bus. An exponential increase is expected in the amount of information being processed, managed, analyzed, and acted upon by enterprise IT. This amazing is not part of some distant future - it is happening today. One report shows a 650% increase in enterprise data by 2020. Other estimates are even higher....
19th Cloud Expo, taking place November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Meanwhile, 94% of enterpri...
Smart Cities are here to stay, but for their promise to be delivered, the data they produce must not be put in new siloes. In his session at @ThingsExpo, Mathias Herberts, Co-founder and CTO of Cityzen Data, will deep dive into best practices that will ensure a successful smart city journey.
From wearable activity trackers to fantasy e-sports, data and technology are transforming the way athletes train for the game and fans engage with their teams. In his session at @ThingsExpo, will present key data findings from leading sports organizations San Francisco 49ers, Orlando Magic NBA team. By utilizing data analytics these sports orgs have recognized new revenue streams, doubled its fan base and streamlined costs at its stadiums. John Paul is the CEO and Founder of VenueNext. Prior ...
Why do your mobile transformations need to happen today? Mobile is the strategy that enterprise transformation centers on to drive customer engagement. In his general session at @ThingsExpo, Roger Woods, Director, Mobile Product & Strategy – Adobe Marketing Cloud, covered key IoT and mobile trends that are forcing mobile transformation, key components of a solid mobile strategy and explored how brands are effectively driving mobile change throughout the enterprise.
Businesses are struggling to manage the information flow and interactions between all of these new devices and things jumping on their network, and the apps and IT systems they control. The data businesses gather is only helpful if they can do something with it. In his session at @ThingsExpo, Chris Witeck, Principal Technology Strategist at Citrix, will discuss how different the impact of IoT will be for large businesses, expanding how IoT will allow large organizations to make their legacy ap...
“We're a global managed hosting provider. Our core customer set is a U.S.-based customer that is looking to go global,” explained Adam Rogers, Managing Director at ANEXIA, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Apache Hadoop is a key technology for gaining business insights from your Big Data, but the penetration into enterprises is shockingly low. In fact, Apache Hadoop and Big Data proponents recognize that this technology has not yet achieved its game-changing business potential. In his session at 19th Cloud Expo, John Mertic, director of program management for ODPi at The Linux Foundation, will explain why this is, how we can work together as an open data community to increase adoption, and the i...
"We have several customers now running private clouds. They're not as large as they should be but it's getting there. The adoption challenge has been pretty simple. Look at the world today of virtualization vs cloud," stated Nara Rajagopalan, CEO of Accelerite, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Internet of @ThingsExpo, taking place November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 19th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation of the Worldwide Web more than 20 years ago. All major researchers estimate there will be tens of billions devices - comp...
Developing software for the Internet of Things (IoT) comes with its own set of challenges. Security, privacy, and unified standards are a few key issues. In addition, each IoT product is comprised of (at least) three separate application components: the software embedded in the device, the back-end service, and the mobile application for the end user’s controls. Each component is developed by a different team, using different technologies and practices, and deployed to a different stack/target –...
What does it look like when you have access to cloud infrastructure and platform under the same roof? Let’s talk about the different layers of Technology as a Service: who cares, what runs where, and how does it all fit together. In his session at 18th Cloud Expo, Phil Jackson, Lead Technology Evangelist at SoftLayer, an IBM company, spoke about the picture being painted by IBM Cloud and how the tools being crafted can help fill the gaps in your IT infrastructure.
A strange thing is happening along the way to the Internet of Things, namely far too many devices to work with and manage. It has become clear that we'll need much higher efficiency user experiences that can allow us to more easily and scalably work with the thousands of devices that will soon be in each of our lives. Enter the conversational interface revolution, combining bots we can literally talk with, gesture to, and even direct with our thoughts, with embedded artificial intelligence, wh...
One of biggest questions about Big Data is “How do we harness all that information for business use quickly and effectively?” Geographic Information Systems (GIS) or spatial technology is about more than making maps, but adding critical context and meaning to data of all types, coming from all different channels – even sensors. In his session at @ThingsExpo, William (Bill) Meehan, director of utility solutions for Esri, will take a closer look at the current state of spatial technology and ar...
According to Forrester Research, every business will become either a digital predator or digital prey by 2020. To avoid demise, organizations must rapidly create new sources of value in their end-to-end customer experiences. True digital predators also must break down information and process silos and extend digital transformation initiatives to empower employees with the digital resources needed to win, serve, and retain customers.